Results of triple marker testing are usually reported as both actual concentration and MoM values, and an individual risk assessment is provided. An MoM is defined as the ratio of an individual marker ...

A new diagnostic strategy that includes three markers may significantly improve the detection and treatment of kidney disease, according to findings published online in the Journal of the American ...

Lucent Diagnostics, a brand of Quanterix (QTRX) Corporation, has introduced LucentAD Complete, a new multi-marker blood test designed to help detect Alzheimer’s Disease (AD) in a broader range of ...